TrialJAMA cardiology2020

Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.

Alexander C Fanaroff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.